Navigation Links
ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics
Date:1/7/2011

lments.

The target company has no employees, but in connection with a transaction ADVENTRX expects to retain the services of certain members of the target company's management team who have been involved in the development of the TPC.

About the Planned Development of the Target Company's Lead Product Candidate

If a transaction is consummated, ADVENTRX expects to conduct a phase 3 clinical trial of the TPC for the treatment of sickle cell crisis. Prior to initiating this study, ADVENTRX would discuss the design and analytical methodologies of the study with the FDA. Based on its evaluation to-date, ADVENTRX believes the out-of-pocket cost to submit an NDA covering the TPC would be approximately $15 million to $25 million over 3 years. ADVENTRX expects to agree to commit approximately $1.5 million to conduct particular activities during the first 12 months following consummation of the acquisition. The principal source of market exclusivity for the TPC for the sickle cell disease indication is expected to be based on orphan drug exclusivity. The FDA has granted an orphan drug designation for the TPC for the treatment of sickle cell crisis.  

The foregoing is based on ADVENTRX's current discussions with the target company. There is no guarantee that definitive agreements will be entered into or that ADVENTRX will consummate a transaction with the target company or that any transaction ADVENTRX ultimately may consummate will be on the terms described above.

About the Target Company's Lead Product Candidate

The TPC is a purified form of a nonionic block copolymer surfactant that is believed to adhere to hydrophobic surfaces that develop when cells are damaged. The TPC is designed to restore hydration lattices and minimize the cascade of adhesive, inflammatory and coagulation responses that cause adhesion of cells, impaired blood flow and tissue ischemia. Improving blood flow in the microvasculatu
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. ADVENTRX Announces Completion of Patient Enrollment in Phase 2 Clinical Trial of CoFactor(R) for the Treatment of Advanced Breast Cancer
5. ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
6. ADVENTRX to Present CoFactor Phase 2 Breast Cancer Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
7. ADVENTRX Announces ANX-530 Safety Data From Registrational Bioequivalence Clinical Study
8. ADVENTRX Presents CoFactor Data at the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO)
9. ADVENTRX Announces CoFactor(R) Phase 2b Clinical Trial Overall Survival Results
10. ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
11. ADVENTRX Completes Patient Enrollment in ANX-514 Bioequivalence Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- SAM ... (Axilla) Strap for the SAM Junctional Tourniquet.  ... SAM Medical Products announced today that ... recall to address a potential issue with a ... for the Axilla application of the SAM Junctional ...
(Date:8/29/2014)... , Aug. 29, 2014  A Boston ... multinational study on stent removability and preliminary long ... been published in the August issue of the ... study 1 is being conducted in 11 ... fully covered self-expanding metal stents (FCSEMS) after extended ...
(Date:8/29/2014)... 29, 2014 Medina Medical announced today that ... of the Board of Directors on August 18, 2014. ... and commercialization experience, including over a decade of direct ... as a Partner of the medical device incubator The ... two Foundry start-ups. Mr. Engelson previously served as the ...
Breaking Medicine Technology:SAM Medical Products Implements Voluntary Recall of its Accessory (Axilla) Strap for the SAM Junctional Tourniquet. 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 2Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 3Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents 4Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2
... , ARDEE, Ireland, Dec. 11 As ... disclosed, its acquisition of the global branded prescription pharmaceuticals ... October 30, 2009 (the "PGP Acquisition"), constituted a change ... (the "Marketing Agreement") between a P&G subsidiary acquired by ...
... , BATESVILLE, Ind., Dec. 11 ... Hill-Rom,s Advanta(TM) 2 Bed for use in medical-surgical areas of hospitals and ... safety features and the flexibility to use a variety of care surfaces ... to our customers. It combines the best features of Hill-Rom,s long-time leader, ...
Cached Medicine Technology:Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 2Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 3Warner Chilcott Considers Potential Repurchase or Redemption of 8.75% Senior Subordinated Notes 4Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 2Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 3Hill-Rom Introduces Innovative Smart Bed for Medical-Surgical Settings 4
(Date:8/30/2014)... 2014 The Truth about Six Pack Abs ... reveal to users some shocking foods that can burn belly ... modeling looks, as well as some motivation secrets for successful ... there is one unique trick that can help users reduce ... what many people might think, cardio exercise routines are not ...
(Date:8/30/2014)... (PRWEB) August 31, 2014 Recently, Skmen.com, ... 2014 long casual dresses . Before the middle ... can enjoy a discounted price, from 15 to 30 ... all the company’s long casual outfits are carefully made ... a graceful look for the wearers. Skmen.com is popular ...
(Date:8/30/2014)... Dayton, OH (PRWEB) August 30, 2014 United ... school’s first fully online degree, the Master of Theological Studies ... completed in 2-3 years, is designed for students who wish ... deepen their understanding and capacity to serve the Church and ... this degree, but now they can attend classes from any ...
(Date:8/30/2014)... 2014 Daily Gossip reveals in its review ... Desire You program, who shows a unique formula to get ... this method says that the program goes beyond mere attraction ... Desire You review indicates that the program was created by ... his great techniques to make a man feel emotionally addicted. ...
(Date:8/30/2014)... The Plastic Surgery Group (PSG) is one ... in the U.S. to provide clients with Vanquish, a ... waists with deep-tissue heating. , Unlike Cryotherapy which kills ... more inclusive to target large sections of desired weight ... about one inch away from their body while the ...
Breaking Medicine News(10 mins):Health News:Truth about Six Pack Abs Review Reveals Unique Method to Eliminate Stubborn Stomach Fat 2Health News:Huge Deals On 2014 Long Casual Dresses Unveiled By Skmen.com 2Health News:United Theological Seminary Announces First Fully Online Degree 2Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:NJ Top Docs Presents, The Plastic Surgery Group 2
... Israel, Nov. 21 Shamir,Optical Industry Ltd. (Nasdaq: ... earnings results on Tuesday, November 27, 2007, and has,scheduled ... A.M. EST that,morning., The conference call will be ... go to http://www.kcsa.com approximately five minutes before,the ...
... 2007 Full-Year Financial Outlook, WOODCLIFF LAKE, N.J., Nov. ... today filed with the U.S.,Securities and Exchange Commission (SEC) ... 2007. The filing of Par,s Form 10-Qs for these ... restating its consolidated,financial statements for certain prior periods, which ...
... Open access online journal,AZoJono* (The AZo Journal ... research edition in conjunction with DESYGN-IT*, an ... investigating the design,synthesis, growth and application of ... URL for special edition,[ http://www.azonano.com/nanotechnology%20journal.asp ...
... 20 CHF,International has been selected as the ... Fund) new Principal Recipient (PR) for,HIV/AIDS prevention, treatment ... awarded an HIV proposal in Round 3 programming., ... years, CHF will be directly responsible for,managing Honduras, ...
... S.C., Nov. 20 BlueCross BlueShield of ... awarded Case Management,Accreditation from URAC, a Washington, ... standards for the health care,industry. URAC,s ... a process to assess, plan and implement ...
... 20 2007 Vase or face" When presented with the well ... the faces of two people, what we observe depends on the ... , In this example, whether you see faces or vases depends ... always stays exactly the same, said John Serences, a UC Irvine ...
Cached Medicine News:Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing Third Quarter 2007 Earnings Results 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 2Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 3Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 4Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 5Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 6Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 7Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 8Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 9Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 10Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 11Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 12Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 13Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 14Health News:Par Pharmaceutical Files Form 10-Qs for First and Second Quarters of 2007 15Health News:Major EU Funded Nanotube Research Group, DESYGN-IT, Publish in AZoJono - The Open Access Online Nanotech Journal 2Health News:CHF International Named Global Fund Principal Recipient in Honduras 2Health News:S.C. BlueCross BlueShield Receives URAC Case Management Accreditation 2Health News:Scientists uncover how the brain controls what the eyes see 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: